Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-24

Clinical Trial Update: Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome [NA]

View source ↗

Summary

A clinical trial update notes an investigation of an aromatase inhibitor to affect bone maturation in children with Silver-Russell syndrome or Prader-Willi synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aromatase inhibitor (Aromatase inhibitor)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Silver Russell Syndrome, Prader-Willi Syndrome | NA | Status: UNKNOWN